Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1987 May;55(5):1029–1036. doi: 10.1128/iai.55.5.1029-1036.1987

Role of high-avidity binding of human neutrophil myeloperoxidase in the killing of Actinobacillus actinomycetemcomitans.

K T Miyasaki, J J Zambon, C A Jones, M E Wilson
PMCID: PMC260463  PMID: 3032796

Abstract

The binding of the neutrophil enzyme myeloperoxidase (MPO) to microbial surfaces is believed to be the first step in its microbicidal activity. The MPO-H2O2-Cl- system is responsible for most oxidative killing of Actinobacillus actinomycetemcomitans by human neutrophils. There appear to be three forms of MPO (MPO I, II, and III), all of which can kill this organism in the presence of H2O2 and chloride. In this study, we characterized the binding of native human neutrophil MPO to A. actinomycetemcomitans by an elution procedure dependent on the cationic detergent cetyltrimethylammonium bromide. Binding of native MPO was rapid and reached apparent equilibrium within 1 min. A proportion of binding under equilibrium conditions was saturable and highly avid, with a capacity of 4,500 sites per cell and a dissociation constant of 7.9 X 10(-10) M. At equal protein concentrations, more MPO III bound than MPO II, and more MPO II bound than MPO I. The high-avidity interaction was inhibitable with yeast mannan and with the serotype-defining mannan of A. actinomycetemcomitans. Binding was also partially reversible with yeast mannan. MPO bound to the high-avidity sites did not oxidize guaiacol but oxidized chloride, as detected by the chlorination of taurine. MPO bound to the high-avidity sites was incapable of killing A. actinomycetemcomitans alone in the presence of H2O2 and Cl-, but potentiated killing when sufficient additional MPO was provided. The killing of A. actinomycetemcomitans by the MPO-H2O2-Cl- system was inhibited by yeast mannan and a serotype-defining mannan of A. actinomycetemcomitans. We conclude that high-avidity binding of MPO to the surface of A. actinomycetemcomitans is a mannan-specific interaction and that MPO bound to the high-avidity sites is essential but not alone sufficient to kill A. actinomycetemcomitans.

Full text

PDF
1033

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bakkenist A. R., Wever R., Vulsma T., Plat H., van Gelder B. F. Isolation procedure and some properties of myeloperoxidase from human leucocytes. Biochim Biophys Acta. 1978 May 11;524(1):45–54. doi: 10.1016/0005-2744(78)90101-8. [DOI] [PubMed] [Google Scholar]
  2. Ballou C. E. Some aspects of the structure, immunochemistry, and genetic control of yeast mannans. Adv Enzymol Relat Areas Mol Biol. 1974;40(0):239–270. doi: 10.1002/9780470122853.ch6. [DOI] [PubMed] [Google Scholar]
  3. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  4. Cainciola L. J., Genco R. J., Patters M. R., McKenna J., van Oss C. J. Defective polymorphonuclear leukocyte function in a human periodontal disease. Nature. 1977 Feb 3;265(5593):445–447. doi: 10.1038/265445a0. [DOI] [PubMed] [Google Scholar]
  5. Clark R. A., Page R. C., Wilde G. Defective neutrophil chemotaxis in juvenile periodontitis. Infect Immun. 1977 Dec;18(3):694–700. doi: 10.1128/iai.18.3.694-700.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Eng R. H., Smith S. M., Goldstein E. J., Miyasaki K. T., Quah S. E., Buccini F. Failure of vancomycin prophylaxis and treatment for Actinobacillus actinomycetemcomitans endocarditis. Antimicrob Agents Chemother. 1986 Apr;29(4):699–700. doi: 10.1128/aac.29.4.699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ganz T., Selsted M. E., Szklarek D., Harwig S. S., Daher K., Bainton D. F., Lehrer R. I. Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest. 1985 Oct;76(4):1427–1435. doi: 10.1172/JCI112120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Henderson W. R., Jong E. C., Klebanoff S. J. Binding of eosinophil peroxidase to mast cell granules with retention of peroxidatic activity. J Immunol. 1980 Mar;124(3):1383–1388. [PubMed] [Google Scholar]
  9. Kiley P., Holt S. C. Characterization of the lipopolysaccharide from Actinobacillus actinomycetemcomitans Y4 and N27. Infect Immun. 1980 Dec;30(3):862–873. doi: 10.1128/iai.30.3.862-873.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Klebanoff S. J., Hamon C. B. Role of myeloperoxidase-mediated antimicrobial systems in intact leukocytes. J Reticuloendothel Soc. 1972 Aug;12(2):170–196. [PubMed] [Google Scholar]
  11. Locksley R. M., Wilson C. B., Klebanoff S. J. Role for endogenous and acquired peroxidase in the toxoplasmacidal activity of murine and human mononuclear phagocytes. J Clin Invest. 1982 May;69(5):1099–1111. doi: 10.1172/JCI110545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Matheson N. R., Wong P. S., Schuyler M., Travis J. Interaction of human alpha-1-proteinase inhibitor with neutrophil myeloperoxidase. Biochemistry. 1981 Jan 20;20(2):331–336. doi: 10.1021/bi00505a016. [DOI] [PubMed] [Google Scholar]
  13. Merrill D. P. Purification of human myeloperoxidase by Concanavalin A-Sepharose affinity chromatography. Prep Biochem. 1980;10(2):133–50. doi: 10.1080/00327488008061729. [DOI] [PubMed] [Google Scholar]
  14. Miyasaki K. T., Wilson M. E., Brunetti A. J., Genco R. J. Oxidative and nonoxidative killing of Actinobacillus actinomycetemcomitans by human neutrophils. Infect Immun. 1986 Jul;53(1):154–160. doi: 10.1128/iai.53.1.154-160.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Miyasaki K. T., Wilson M. E., Cohen E., Jones P. C., Genco R. J. Evidence for and partial characterization of three major and three minor chromatographic forms of human neutrophil myeloperoxidase. Arch Biochem Biophys. 1986 May 1;246(2):751–764. doi: 10.1016/0003-9861(86)90332-2. [DOI] [PubMed] [Google Scholar]
  16. Miyasaki K. T., Wilson M. E., Genco R. J. Killing of Actinobacillus actinomycetemcomitans by the human neutrophil myeloperoxidase-hydrogen peroxide-chloride system. Infect Immun. 1986 Jul;53(1):161–165. doi: 10.1128/iai.53.1.161-165.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Miyasaki K. T., Wilson M. E., Zambon J. J., Genco R. J. Influence of endogenous catalase activity on the sensitivity of the oral bacterium Actinobacillus actinomycetemcomitans and the oral haemophili to the bactericidal properties of hydrogen peroxide. Arch Oral Biol. 1985;30(11-12):843–848. doi: 10.1016/0003-9969(85)90141-4. [DOI] [PubMed] [Google Scholar]
  18. Odeberg H., Olsson I. Microbicidal mechanisms of human granulocytes: synergistic effects of granulocyte elastase and myeloperoxidase or chymotrypsin-like cationic protein. Infect Immun. 1976 Dec;14(6):1276–1283. doi: 10.1128/iai.14.6.1276-1283.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Olsen R. L., Little C. Purification and some properties of myeloperoxidase and eosinophil peroxidase from human blood. Biochem J. 1983 Mar 1;209(3):781–787. doi: 10.1042/bj2090781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Paul B. B., Jacobs A. A., Strauss R. R., Sbarra A. J. Role of the Phagocyte in Host-Parasite Interactions XXIV. Aldehyde Generation by the Myeloperoxidase-H(2)O(2)-Chloride Antimicrobial System: a Possible In Vivo Mechanism of Action. Infect Immun. 1970 Oct;2(4):414–418. doi: 10.1128/iai.2.4.414-418.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pember S. O., Shapira R., Kinkade J. M., Jr Multiple forms of myeloperoxidase from human neutrophilic granulocytes: evidence for differences in compartmentalization, enzymatic activity, and subunit structure. Arch Biochem Biophys. 1983 Mar;221(2):391–403. doi: 10.1016/0003-9861(83)90158-3. [DOI] [PubMed] [Google Scholar]
  22. Ramsey P. G., Martin T., Chi E., Klebanoff S. J. Arming of mononuclear phagocytes by eosinophil peroxidase bound to Staphylococcus aureus. J Immunol. 1982 Jan;128(1):415–420. [PubMed] [Google Scholar]
  23. Robertson P. B., Lantz M., Marucha P. T., Kornman K. S., Trummel C. L., Holt S. C. Collagenolytic activity associated with Bacteroides species and Actinobacillus actinomycetemcomitans. J Periodontal Res. 1982 May;17(3):275–283. doi: 10.1111/j.1600-0765.1982.tb01154.x. [DOI] [PubMed] [Google Scholar]
  24. Saglie F. R., Carranza F. A., Jr, Newman M. G., Cheng L., Lewin K. J. Identification of tissue-invading bacteria in human periodontal disease. J Periodontal Res. 1982 Sep;17(5):452–455. doi: 10.1111/j.1600-0765.1982.tb02024.x. [DOI] [PubMed] [Google Scholar]
  25. Selvaraj R. J., Zgliczynski J. M., Paul B. B., Sbarra A. J. Enhanced killing of myeloperoxidase-coated bacteria in the myeloperoxidase-H2O2-Cl- system. J Infect Dis. 1978 Apr;137(4):481–485. doi: 10.1093/infdis/137.4.481. [DOI] [PubMed] [Google Scholar]
  26. Shafer W. M., Martin L. E., Spitznagel J. K. Cationic antimicrobial proteins isolated from human neutrophil granulocytes in the presence of diisopropyl fluorophosphate. Infect Immun. 1984 Jul;45(1):29–35. doi: 10.1128/iai.45.1.29-35.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Shenker B. J., McArthur W. P., Tsai C. C. Immune suppression induced by Actinobacillus actinomycetemcomitans. I. Effects on human peripheral blood lymphocyte responses to mitogens and antigens. J Immunol. 1982 Jan;128(1):148–154. [PubMed] [Google Scholar]
  28. Slots J., Rosling B. G. Suppression of the periodontopathic microflora in localized juvenile periodontitis by systemic tetracycline. J Clin Periodontol. 1983 Sep;10(5):465–486. doi: 10.1111/j.1600-051x.1983.tb02179.x. [DOI] [PubMed] [Google Scholar]
  29. Stelmaszyńska T., Zgliczyński J. M. Myeloperoxidase of human neutrophilic granulocytes as chlorinating enzyme. Eur J Biochem. 1974 Jun 1;45(1):305–312. doi: 10.1111/j.1432-1033.1974.tb03555.x. [DOI] [PubMed] [Google Scholar]
  30. Sundqvist G., Johansson E. Bactericidal effect of pooled human serum on Bacteroides melaninogenicus, Bacteroides asaccharolyticus and Actinobacillus actinomycetemcomitans. Scand J Dent Res. 1982 Feb;90(1):29–36. doi: 10.1111/j.1600-0722.1982.tb01521.x. [DOI] [PubMed] [Google Scholar]
  31. Tsai C. C., Hammond B. F., Baehni P., McArthur W. P., Taichman N. S. Interaction of inflammatory cells and oral microorganisms. VI. Exocytosis of PMN lysosomes in response to gram-negative plaque bacteria. J Periodontal Res. 1978 Nov;13(6):504–512. doi: 10.1111/j.1600-0765.1978.tb00204.x. [DOI] [PubMed] [Google Scholar]
  32. Tsai C. C., Shenker B. J., DiRienzo J. M., Malamud D., Taichman N. S. Extraction and isolation of a leukotoxin from Actinobacillus actinomycetemcomitans with polymyxin B. Infect Immun. 1984 Feb;43(2):700–705. doi: 10.1128/iai.43.2.700-705.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Weiss J., Beckerdite-Quagliata S., Elsbach P. Resistance of gram-negative bacteria to purified bactericidal leukocyte proteins: relation to binding and bacterial lipopolysaccharide structure. J Clin Invest. 1980 Mar;65(3):619–628. doi: 10.1172/JCI109707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Weiss S. J., Klein R., Slivka A., Wei M. Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J Clin Invest. 1982 Sep;70(3):598–607. doi: 10.1172/JCI110652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Weiss S. J., Peppin G., Ortiz X., Ragsdale C., Test S. T. Oxidative autoactivation of latent collagenase by human neutrophils. Science. 1985 Feb 15;227(4688):747–749. doi: 10.1126/science.2982211. [DOI] [PubMed] [Google Scholar]
  36. Wright C. D., Bowie J. U., Nelson R. D. Influence of yeast mannan on release of myeloperoxidase by human neutrophils: determination of structural features of mannan required for formation of myeloperoxidase-mannan-neutrophil complexes. Infect Immun. 1984 Feb;43(2):467–471. doi: 10.1128/iai.43.2.467-471.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Wright C. D., Herron M. J., Gray G. R., Holmes B., Nelson R. D. Influence of yeast mannan on human neutrophil functions: inhibition of release of myeloperoxidase related to carbohydrate-binding property of the enzyme. Infect Immun. 1981 May;32(2):731–738. doi: 10.1128/iai.32.2.731-738.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Yamada M., Mori M., Sugimura T. Purification and characterization of small molecular weight myeloperoxidase from human promyelocytic leukemia HL-60 cells. Biochemistry. 1981 Feb 17;20(4):766–771. doi: 10.1021/bi00507a018. [DOI] [PubMed] [Google Scholar]
  39. Zambon J. J. Actinobacillus actinomycetemcomitans in human periodontal disease. J Clin Periodontol. 1985 Jan;12(1):1–20. doi: 10.1111/j.1600-051x.1985.tb01348.x. [DOI] [PubMed] [Google Scholar]
  40. Zambon J. J., Slots J., Miyasaki K., Linzer R., Cohen R., Levine M., Genco R. J. Purification and characterization of the serotype c antigen from Actinobacillus actinomycetemcomitans. Infect Immun. 1984 Apr;44(1):22–27. doi: 10.1128/iai.44.1.22-27.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES